Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2311 (LINC02311) is a human gene that transcribes a long non-coding RNA molecule. LINC02311 belongs to the class of lncRNAs, defined by their lack of coding potential for proteins and localization in intergenic regions of the genome. Current mainstream genetic databases recognize its nomenclature and sequence, but as of September 2025, there are no reliable reports of its biological function, disease relevance, or pharmacological targeting in experimental or clinical settings. LINC02311 should not be confused with similarly named lncRNAs (such as LINC00511) that are well-characterized in cancer biology. Further research is required to determine any potential physiological or pathogenic significance of LINC02311[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2311 (LINC02311).